Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Author Correction: B lymphocyte-derived acetylcholine limits steady-state and emergency hematopoiesis

The Original Article was published on 28 March 2022

Correction to: Nature Immunology, published online 28 March 2022.

In the version of this article originally published, there were phrasing errors in the last sentence of the Abstract (corrected to read “Pharmacologic inhibition of acetylcholine esterase decreased the systemic supply of inflammatory myeloid cells in mice and humans with cardiovascular disease”), in the second sentence of the Discussion (corrected to read “We found decreased numbers of leukocytes in humans and mice treated with acetylcholine esterase inhibitors, and increased leukocyte numbers in mice with B cell-specific deletion of the gene encoding the enzyme Chat…”), and in the fourth sentence of the Discussion (corrected to read “Cd19CreChatfl/fl mice with atherosclerosis or post-MI heart failure had increased cardiovascular inflammation and worse disease outcomes”). The changes have been made in the HTML and PDF versions of the article.

Author information

Authors and Affiliations


Corresponding author

Correspondence to Matthias Nahrendorf.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Schloss, M.J., Hulsmans, M., Rohde, D. et al. Author Correction: B lymphocyte-derived acetylcholine limits steady-state and emergency hematopoiesis. Nat Immunol 23, 1285 (2022).

Download citation

  • Published:

  • Issue Date:

  • DOI:


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing